Oxycodone
Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Published , updated
414984009
Articles
19th December 2019
What naloxone doses should be used in adults to urgently reverse the effects of opioids?
The opioid antagonist, naloxone, is a highly effective antidote the use of which is potentially life-saving. The drug has a role in a wide range… Buprenorphine Diamorphine Emergency medicine and urgent care Fentanyl Medicines Safety Methadone Morphine Naloxone Oxycodone Palliative and End of Life Care Pethidine Q&A
20th December 2018
Which opioids can be used in renal impairment?
Opioids are used in a wide variety of clinical settings and are well established for the treatment of both acute and chronic pain. Renal impairment… Alfentanil Anaesthesia and pain Buprenorphine Codeine Diamorphine Dihydrocodeine Fentanyl Hydromorphone Methadone Morphine Oxycodone Pethidine Q&A Renal and urologic disorders Tramadol
29th January 2018
In use product safety assessment report: Onexila® XL (oxycodone once daily prolonged release tablets)
A UKMi Product Safety assessment on Onexila® XL (oxycodone once daily prolonged release tablets); in-use medication safety considerations resultant from the product presentation or other… Anaesthesia and pain Medicines Safety News Oxycodone
14th December 2016
What is serotonin syndrome and which medicines cause it?
This Medicines Q&A outlines the causes and symptoms of serotonin syndrome and lists examples of medicines with the potential to cause serotonin syndrome Almotriptan Amitriptyline Bupropion Buspirone Carbamazepine Chlorphenamine Citalopram Clomipramine Dextromethorphan Dosulepin Doxepin Duloxetine Eletriptan Ergotamine Escitalopram Fentanyl Fluoxetine Fluvoxamine Frovatriptan Granisetron Imipramine Isocarboxazid Levodopa Linezolid Lithium Lofepramine Mental Health Methadone Methylthioninium chloride Metoclopramide Mirtazapine Moclobemide Naratriptan Nortriptyline Ondansetron Oxitriptan Oxycodone Paroxetine Pentazocine Pethidine Phenelzine Procarbazine Q&A Rasagiline Rizatriptan Selegiline Sertraline Sodium valproate St. John's wort Sumatriptan Tapentadol Tramadol Tranylcypromine Trazodone Trimipramine Tryptophan Venlafaxine Zolmitriptan
12th October 2016
What are the equivalent doses of oral morphine to other oral opioids when used as analgesics in adult palliative care?
Morphine is generally the strong opioid of choice for treating moderate to severe cancer pain and a common question is how to convert a dose… Anaesthesia and pain Buprenorphine Codeine Dihydrocodeine Hydromorphone Morphine Oxycodone Palliative and End of Life Care Q&A Tapentadol Tramadol
16th October 2014
Can opioids be used for pain relief during pregnancy?
There are no specific guidelines for the treatment of pain in pregnancy. Not all analgesics are suitable for use during or at certain stages of… Anaesthesia and pain Codeine Dihydrocodeine Morphine Obstetrics and gynaecology Oxycodone Q&A Tapentadol Tramadol
20th May 2012
Safety in Lactation: Opioid analgesics
The evidence relating to the safe use of opioid analgesics in breastfeeding mothers is very variable between individual drugs. This group of drugs presents a… Buprenorphine Codeine Diamorphine Dihydrocodeine Dipipanone + Cyclizine Fentanyl Hydromorphone Meptazinol Methadone Morphine Oxycodone Papaveretum Pentazocine Pethidine Tapentadol TramadolMedicine Compliance Aid Stability
OxyNorm · Napp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
OxyNorm
Capsules - various strengths
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
11th May 2015
Oxycontin · Napp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
Oxycontin
Tablets f/c, m/r various strengths
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
11th May 2015
Targinact · Napp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
Targinact
Tablets f/c, m/r - various strengths
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container and protect from light
11th May 2015
Lactation Safety Information
Oral / Parenteral
Oral / Parenteral
Dihydrocodeine, Morphine or other appropriate analgesic
Includes combinations with naloxone
Dose-dependent sedation has occurred in breastfed infants
Doses greater than 40mg/day should be avoided in breast feeding mothers
Oxycodone elimination in young infants is both variable and decreased
Avoid in neonates and monitor young infants (see summary)